Limitations in the clinical assessment of obesity: Comments on the American Heart Association's 2006 statement [1];Limitaciones de la valoración clínica de obesidad: Reflexiones a propósito de la declaración de la American Heart Association de 2006

Revista Espanola de Cardiologia

Volumn 60, Issue 9, 2007, Pages 992-993

  Morales, Alberto ^a   Marrugat, Jaume ^b   Coca, Antonio ^c  

^a Cardiocentro Ernesto Che Guevara   (Cuba)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; COMORBIDITY; HUMAN; LETTER; OBESITY; PROBABILITY; UNITED STATES; CARDIOLOGY; MEDICAL SOCIETY;

CARDIOLOGY; HUMANS; OBESITY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 35748953147     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13109655     Document Type: Letter

References (15)

1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: An update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease From the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898-918.
2. Kannel WB, LeBauer EJ, Dawber TR, McNamara PM. Relation of body weight to development of coronary heart disease: The Framingham Study. Circulation. 1967;35:734-44.
3. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation. 1998;97:2099-100.
4. National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health; 1998. Disponible en: http://www.nhlbi.nih.gov/ guidelines/obesity/ob_gdlns.htm
5. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595-600.
6. Seidell JC, Flegal KM. Assessing obesity: classification and Epidemiology. Br Med Bull. 1997;53:238-52.
7. Prentice AM, Jebb SA. Beyond body mass index. Obes Rev. 2000;2:141-7.
8. Bagust A, Walley T. An alternative to body mass index for standardizing body weight for stature. Q J Med. 2000;93:589-96.
9. Wilson PW, D'Agostino RB, Sullivan L, Parice H, Kannel WB. Overweight and Obesity as Determinants of Cardiovascular Risk. The Framingham Experience. Arch Intern Med. 2002;162:1867-72.
10. Silventoinen K, Zdravkovic S, Skytthe A, McCarron P, Herskind AM, Koskenvuo M, et al. Association between Height and Coronary Heart Disease Mortality: A Prospective Study of 35,000 Twin Pairs. Am J Epidemiol. 2006;163:615-21.
11. Palmer JR, Rosenberg L, Shapiro S. Stature and the risk of myocardial infarction in women. Am J Epidemiol. 1990;132:27-32.
12. Li TY, Rana JS, Manson JE, Manson JE, Willet WC, Stampfer MJ, et al. Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation. 2006;113:499-506.
13. Covas MI, Nyyssonen K, Poulsen H, Kaikkonen J, Zunft HJ, Kiesewetter H, et al. The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors A Randomized Trial. Ann Intern Med. 2006;145:333-41.
14. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366:1640-9.
15. Elosúa R, García M, Aguilar A, Molina L, Covas MA, Marrugat J, et al. Validation of the Minnesota Leisure Time Physical Activity Questionnaire in Spanish Women. Med Sci Sports Exerc. 2000;32:1431-7.